Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - February 2023

Click here to read the articles and download the PDF

Disruptive Factors Shape RA Landscape

The need for expert strategies to improve rheumatoid arthritis (RA) therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Introducing Value & Access

New Pharma Commerce column addresses the relevance of pricing.

Pharma Cold Chain in Search of Equilibrium

Post-pandemic conditions are improving for the temperature-controlled market, but, meanwhile, the technical demands are rising.

Feds to Review March-In Authority on Drug Patents

March 24, 2023

Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.

Using Pharmacovigilance Platforms to One’s Advantage

March 17, 2023

How these applications—combined with artificial intelligence, machine learning, and natural language processing—influence workflows.

FDA Finalizes the Definitions of 'Suspect and Illegitimate' Pharma Products

March 17, 2023

Industry is still scrambling to handle clerical errors of DSCSA transactions.

HDA’s 2023 Distribution Management Conference Dives into DSCSA Specifics and More

March 16, 2023

Event—taking place in Indianapolis—places supply chain education at the forefront.

NABP Hopes to Fill a Key Gap in DSCSA Compliance: Local Pharmacies

March 15, 2023

The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.

Advancing ‘Smart Pharma’ Capabilities in 2023 and Beyond

March 13, 2023

Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.

Arranta Bio Doubles RNA Process Development Capacity at Massachusetts Plant

March 10, 2023

Project addresses customer demand in GMP-powered advanced therapeutics.

InVita Healthcare Technologies Launches Counterfeit Drug Testing Software

March 09, 2023

In an effort to strengthen supply chain, unnamed pharma company to use chain of custody application to combat an illegal global market worth up to $200 billion annually.

Evonik Opens Pharmaceutical Lipids Facility in Germany

March 09, 2023

New site is expected to complement CDMO’s commercial production experience.

Framework Solutions Gains Additional Regulatory Operations Experience, Purchases Onix Life Sciences

March 08, 2023

Acquisition expands company’s eCTD submission capabilities.